Organic Growth and Thorne Acquisition Drive Procter & Gamble Earnings

Procter & Gamble attributed its acquisition of Thorne as a reason for its guidance raise. (Daniel Acker/Bloomberg)

Key Points

• Procter & Gamble raises its all-in sales growth guidance to a range of 2% to 4% following its $3.8 billion acquisition of Thorne.
• The company reports fiscal first-quarter revenue of $23.28 billion and adjusted earnings of $2 a share, both beating Wall Street expectations.
• Procter & Gamble shares rise in premarket trading Thursday.

A recent acquisition coupled with solid organic growth have given Procter & Gamble stock a lift Thursday.

The consumer packaged goods company raised its guidance for its all-in sales growth, thanks to its recent acquisition of health and supplement brand Thorne. On top of that acquisition, Proctor & Gamble saw growth increases across all its product categories, a big turnaround from the prior quarter when some segments were flat or slightly lower.

Revenue grew 4% to $23.28 billion in the fiscal first quarter, above Wall Street’s call for $22.79 billion. Adjusted earnings of $2 a share topped analysts’ consensus estimates of $1.88.

“While we expect there will continue to be geopolitical and economic challenges, this strong start keeps us on track to deliver within our guidance ranges for organic sales growth, core EPS growth and free cash flow productivity for the fiscal year,” CEO Shailesh Jejurikar said Thursday.

The Barron’s Daily

A morning briefing on what you need to know in the day ahead, including exclusive commentary from Barron’s and MarketWatch writers.

Email addressSubscribe

I agree to the Terms of Use, Privacy Notice and Cookie Notice.

I would like to receive updates and special offers from Dow Jones and affiliates.

Shares of Procter & Gamble advanced 3.2% to $161.88 in premarket trading Thursday.

Procter & Gamble raised its outlook for all-in sales growth, saying it now expects a 2% to 4% growth range, up from previous guidance of 1% to 3%. It also reiterated its fiscal 2027 guidance, anticipating adjusted earnings to range from $6.89 to $7.11 a share. Procter & Gamble said it still expects organic sales to grow 1% to 3%.

Wall Street forecasts fiscal 2027 earnings of $6.97 a share with sales growing about 2.1%, according to FactSet.

Management attributed the all-in sales guidance boost to its acquisition of health and supplement brand Thorne for $3.8 billion, which was completed as of Oct. 1. The company previously announced the deal in early August.

Each of Procter & Gamble’s product categories, which range from baby care to hair care, saw a boost in the first quarter. For the period, from July to September, the beauty segment rose 5% from a year ago, with other businesses like health care and home products growing 3% and 5%, respectively.

Write to Mariapaula Gonzalez at mariapaula.gonzalez@barrons.com

Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8